Specialty Pharmacy

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses the relationship between limited distribution networks and specialty pharmacy.

A diagnostic blood test could diagnose patients in early stages of non-alcoholic fatty liver disease.

Top news of the day from across the health care landscape.

HIV compromises the immune system, making patients more susceptible to tuberculosis.

Developing industry connections is crucial for aspiring pharmacists.

Tecentriq is the first anti-PDL1 cancer immunotherapy approved for metastatic non-small cell lung cancer.

Adalimumab also found to be effective in treating non-infectious uveitis.

T cell subset may play a crucial role in the development of diabetes.

Niraparib significantly improved outcomes of platinum-sensitive recurrent ovarian cancer in landmark trial.

A unique pattern of motion by repair proteins allows them to rapidly scan long DNA and flag repair machinery in condition that can lead to skin cancer.

Coinfection with HIV plus a hepatitis B, C, or both, adds to the risk of non-Hodgkins lymphoma.

Acceptance and utilization of biosimilar drugs still in need of improvement within specialty pharmacy.

Study finds that a food-poisoning bacteria increases the growth of gut bacteria linked to Crohn’s disease.

Adjuvant therapy that improves outcomes for kidney cancer patients may finally be an option.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how to address the challenge of access to high cost specialty medications.

An award of $347 million has been given to 16 organizations involved with the Hospital Improvement and Innovation Network.

Dupilumab shows benefits for the treatment of asthma and atopic dermatitis.

Ilaris is the first FDA-approved biologic treatment for Tumor Necrosis Factor–Receptor Associated Periodic Syndrome, Hyperimmunoglobulin D Syndrome/Mevalonate Kinase Deficiency and Familial Mediterranean Fever.

Cromolyn sodium associated with reduced liver fibrosis.

Top news of the week in oncology, and cancer drug development.

After keeping her multiple sclerosis diagnosis a secret for more than a decade, Jamie-Lynn Sigler, teamed up with Biogen’s MS campaign.

Results from a phase 3 trial demonstrates that nintedanib improved progression-free survival, but not overall survival in colon cancer patients.

A special technique allowed researchers to detail the structure of an enzyme that causes antibiotic resistance.

Top news of the day from across the health care landscape.

Mytesi is the only FDA approved treatment for noninfectious diarrhea in HIV positive patients.

Top articles of the week on Specialty Pharmacy Times.

Pharmacist allegedly dispensed different medications instead of Abilify for schizophrenia.

Atezolizumab demonstrated significant improvement in survival compared with docetaxel in individuals with non-small cell lung cancer.